TownSquare Capital’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-27,337
Closed -$250K 1104
2023
Q2
$250K Sell
27,337
-4,425
-14% -$41.2K ﹤0.01% 942
2023
Q1
$300K Sell
31,762
-1,853
-6% -$16.9K 0.01% 830
2022
Q4
$335K Buy
33,615
+2,298
+7% +$25.5K 0.01% 774
2022
Q3
$374K Buy
31,317
+208
+0.7% +$2.08K 0.01% 542
2022
Q2
$255K Buy
31,109
+1,254
+4% +$10.7K 0.01% 587
2022
Q1
$237K Buy
29,855
+18,892
+172% +$163K 0.01% 640
2021
Q4
$103K Sell
10,963
-4,930
-31% -$59.1K ﹤0.01% 697
2021
Q3
$251K Buy
15,893
+5,161
+48% +$92.7K 0.01% 610
2021
Q2
$232K Buy
+10,732
New +$217K 0.01% 555

Other funds holding AXGN

TownSquare Capital's AXGN Position: Q3 2023 in Review

TownSquare Capital sold out of Axogen (AXGN) in Q3 2023, closing a stake of 27,337 shares — an estimated $250K sold.

TownSquare Capital first reported a position in AXGN in Q2 2021 and held it in 9 quarters. The position peaked at $374K in Q3 2022. 119 funds tracked by Wall St. Rank hold AXGN as of Q3 2023.

  • TownSquare Capital reported no remaining Axogen position as of Q3 2023 after selling out during the quarter.
  • TownSquare Capital sold 27,337 Axogen shares in Q3 2023, an estimated $250K.
  • TownSquare Capital first reported a position in Axogen in Q2 2021 and held it in 9 quarters.
  • TownSquare Capital's Axogen position peaked at $374K in Q3 2022.
  • 119 funds tracked by Wall St. Rank held Axogen as of Q3 2023.

Based on TownSquare Capital's 13F filing for Q3 2023, filed 15 Nov 2023.